PHP
ELV icon

Parkman Healthcare Partners’s Elevance Health ELV Stock Holding History

Parkman Healthcare Partners’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-27,751
Closed -$15M – 96
2024
Q2 		$15M Buy
27,751
+12,587
+83% +$6.65M 2.01% 13
2024
Q1 		$7.86M Buy
+15,164
New +$7.54M 0.96% 38
2023
Q2 		– Sell
-21,643
Closed -$9.95M – 98
2023
Q1 		$9.95M Buy
21,643
+9,347
+76% +$4.45M 2.16% 11
2022
Q4 		$6.31M Sell
12,296
-4,900
-28% -$2.49M 1.68% 17
2022
Q3 		$7.81M Sell
17,196
-554
-3% -$265K 2.22% 13
2022
Q2 		$8.57M Buy
+17,750
New +$8.78M 3.15% 8

Other funds holding ELV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Parkman Healthcare Partners's ELV Position: Q3 2024 in Review

Parkman Healthcare Partners sold out of Elevance Health (ELV) in Q3 2024, closing a stake of 27,751 shares — an estimated $15M sold.

Parkman Healthcare Partners first reported a position in ELV in Q2 2022 and held it in 6 quarters. The position peaked at $15M in Q2 2024. 1,694 funds tracked by Wall St. Rank hold ELV as of Q3 2024.

  • Parkman Healthcare Partners reported no remaining Elevance Health position as of Q3 2024 after selling out during the quarter.
  • Parkman Healthcare Partners sold 27,751 Elevance Health shares in Q3 2024, an estimated $15M.
  • Parkman Healthcare Partners first reported a position in Elevance Health in Q2 2022 and held it in 6 quarters.
  • Parkman Healthcare Partners's Elevance Health position peaked at $15M in Q2 2024.
  • 1,694 funds tracked by Wall St. Rank held Elevance Health as of Q3 2024.

Based on Parkman Healthcare Partners's 13F filing for Q3 2024, filed 14 Nov 2024.